Sign in to view content

48-Week End of Study Results From BEHOLD Phase 2 Study of UBX1325 in Patients With DME

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2023

Related

Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial
Nancy M. Holekamp, MD, FASRS
Updates from the Field
2016
Factors Predicting Vitreous Hemorrhage or Neovascularization after Pan-Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Jose Davila, MD
Updates from the Field
2020
Diabetic Retinopathy Take Home Panel
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more